Skip to main content

Alivus Life Sciences Shareholding Pattern

ALIVUS

Small Cap | Pharmaceuticals

₹1374.20

-5.10 (0.37%)

Glenmark Life Sciences Ltd - Shareholding FAQs

The promoter shareholding of Glenmark Life Sciences Ltd is 74.87%.
The FII and DII shareholding of Glenmark Life Sciences Ltd is 5.54% and 7.18%, respectively.
The retail shareholding of Glenmark Life Sciences Ltd is 12.41%.

Open Free Demat Account!

Join our 3.8 Cr+ happy customers

+91
Enjoy Zero Brokerage on Equity Delivery
10 Cr+DOWNLOADS

Enjoy ₹0 Account Opening Charges

Get the link to download the App

Scan this QR code to download the app
Get it on Google PlayDownload on the App Store